Previous issue | Volume 86 | ESPE2016 | Next issue

55th Annual ESPE

Paris, France
10 Sep 2016 - 12 Sep 2016

Card image cap
Paris, France: 10-12 September 2016 Further information

Free Communications

Management of Obesity

Quantitative Proteomic of Rat Livers Shows a Major Reprogramming of Mitochondrial Enzymes in Food-Restriction and Increased Stress Hallmarks in Ad Libitum Feeding
aSchneider Children’s Medical Center, Petach-Tikva, Israel; bTel Aviv University, Tel Aviv, Israel; cUniversity of Zadar, Zadar, Croatia; dUniversity of Lausanna, Lausanna, Switzerland
hrp0086fc13.1
Measurement of Immunofunctional Leptin to Detect Patients with Functional Leptin Deficiency
aDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, Ulm University, Ulm, Germany; bMediagnost GmbH, Reutlingen, Germany; cDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, University of Tübingen, Tübingen, Germany; dInstitute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University of Leipzig, Leipzig, Germany
hrp0086fc13.2
Hypothalamic Gliosis in Obese Children and Adolescents
aFaculty of Medical Sciences, University of Campinas, Campinas, Sao Paulo, Brazil; bDepartment of Pediatrics, University of Campinas, Campinas, Sao Paulo, Brazil; cDepartment of Neurology, University of Campinas, Campinas, Sao Paulo, Brazil; dDivision of General Internal Medicine, University of Washington, Seattle, Washington, USA; eLaboratory of Cell Signaling, University of Campinas, Campinas, Sao Paulo, Brazil
hrp0086fc13.3
Efficacy and Safety of Duodenal-Jejunal Bypass Liner in Morbidly Obese Adolescents-1 Year Experience
aDepartment of Endocrinology, Diabetes and Metabolism, University Children’s Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia; bMedical Faculty Ljubljana, Ljubljana, Slovenia; cDepartment of Gastroenterology, Hepatology and Nutrition, University Children’s Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia
hrp0086fc13.4
Effects of AZP-531, a First-in-Class Unacylated Ghrelin Analog, on Food-Related Behaviour in Prader-Willi Patients: A Multi-Center, Randomized, Placebo-Controlled Study
aAlizé Pharma, Ecully, France; bEndocrinology and Nutrition Department, Sabadell University Hospital, Corporació Sanitària Parc Taulí, Research Institute I3PT, Sabadell, Spain; cNutrition Department, Institute of cardiometabolism and Nutrition, Pitié-Salpêtrière Hospital, Paris, France; dMarin Hospital, Hendaye, France; eRangueil Hospital, Toulouse, France; fDepartment of Endocrinology, Bone Diseases, Genetics, and Gynaecology, Children’s Hospital, Toulouse, France; gAutoimmune Endocrine Diseases Unit, Bambino Gesù, Research Hospital, Palidoro, Rome, Italy; hDepartment of Endocrinology, Diabetes and Nutrition, Angers’ Hospital, Angers, France; iDivision of Auxology, Istituto Auxologico Italiano, Piancavallo, Verbania, Italy
hrp0086fc13.5
Treatment for Early Onset and Extreme Obesity in Two POMC Deficient Patients: Successful Weight Loss with the Melanocortin-4 Receptor Agonist Setmelanotide
aInstitute for Experimental Pediatric Endocrinology, Charité Universitätsmedizin Berlin, Berlin, Germany; bNutrition Department, Institute of Cardiometabolism and Nutrition, ICAN, Assistance-Publique Hôpitaux de Paris, Paris, France; cRhythm Pharmaceuticals, Boston, USA; dDepartment for Pediatric Endocrinology and Diabetes, Charité Universitätsmedizin Berlin, Berlin, Germany
hrp0086fc13.6